中国科技核心期刊
中国科技论文统计源期刊
中文生物医学期刊文献数据库
中国科学引文数据库(CSCD收录)
中国学术期刊综合评价数据库统计源期刊
《中国学术期刊影响因子年报》统计源期刊
Chinese Journal of Blood Purification ›› 2018, Vol. 17 ›› Issue (01): 6-8.doi: 10.3969/j.issn.1671-4091.2017.01.002
Previous Articles Next Articles
Received:
Revised:
Online:
Published:
Abstract: In anemia associated with renal disease, erythropoiesis is suppressed due to inadequate erythropoietin(EPO) production in kidney, inflammation and iron deficiency. Studies have found that hypoxia inducible factor (HIF) is a key regulator for erythropoiesis and iron metabolism and an effective stimulant for the production of endogenous erythropoietin, through which ferritin level is reduced and iron metabolism is balanced. This review discusses the regulatory effects of HIF on EPO, iron metabolism and bone marrow hematopoiesis, and also introduces the HIF pathway as a novel target for the treatment of renal anemia.
Key words: renal anemia, hypixia inducible factor, hypoxia inducible factor prolyl hydroxylase inhibitor
0 / / Recommend
Add to citation manager EndNote|Reference Manager|ProCite|BibTeX|RefWorks
URL: https://www.cjbp.org.cn/EN/10.3969/j.issn.1671-4091.2017.01.002
https://www.cjbp.org.cn/EN/Y2018/V17/I01/6